Example: Heart Attack

Clinical Trials on Neuromyelitis Optica Spectrum Disorder

Total 80 results

NCT02836327

Recruiting

Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders

Conditions: Multiple Sclerosis; Neuromyelitis Optica Spectrum Disorders
NCT02200770

Completed

N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders

Conditions: Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
NCT03819413

Completed

Clinical Patterns of Neuromyelitis Optica Spectrum Disorders in Assiut University Hospital

Conditions: Neuromyelitis Optica Spectrum Disorder
NCT04064944

Not yet recruiting

Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum Disorders

Conditions: Neuromyelitis Optica Spectrum Disorder
NCT04660539

Recruiting

A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Conditions: Neuromyelitis Optica Spectrum Disorder
NCT04256252

Completed

Rituximab at Low dosE for neuromyelitiS optiCa spectrUm disordEr (RESCUE)

Conditions: Neuromyelitis Optica Spectrum Disorder
NCT04146285

Not yet recruiting

A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders

Conditions: Neuromyelitis Optica Spectrum Disorders
NCT04155424

Recruiting

A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder

Conditions: Neuromyelitis Optica; Neuromyelitis Optica Spectrum Disorder
NCT04101058

Enrolling by invitation

Treatment Response Among Chinese Neuromyelitis Optica Spectrum Disorders

Conditions: Neuromyelitis Optica Spectrum Disorders
NCT02893111

Completed

Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder

Conditions: Neuromyelitis Optica Spectrum Disorder
NCT01845584

Completed

Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.

Conditions: Neuromyelitis Optica Spectrum Disorder
NCT03330418

Recruiting

A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum Disorders

Conditions: Neuromyelitis Optica Spectrum Disorders
NCT03350633

Completed

Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders

Conditions: Neuromyelitis Optica Spectrum Disorders; Neuromyelitis Optica
NCT02276963

Completed

Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses

Conditions: Neuromyelitis Optica; Neuromyelitis Optica Spectrum Disorder
NCT02809079

Unknown status

Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients

Conditions: Neuromyelitis Optica Spectrum Disorders; Mycophenolate Mofetil; Efficacy and Safety
NCT03605238

Withdrawn

Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20

Conditions: Neuromyelitis Optica Spectrum Disorder
NCT02073279

Active, not recruiting

Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

Conditions: Neuromyelitis Optica (NMO); NMO Spectrum Disorder (NMOSD)
NCT03062579

Completed

A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD

Conditions: Neuromyelitis Optica Spectrum Disorders; Neuromyelitis Optica; Devic's Disease
NCT03766347

Recruiting

Pediatric NMOSD Observational Study

Conditions: Neuromyelitis Optica; NMO Spectrum Disorder
NCT02249676

Completed

Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders

Conditions: Devic's Syndrome; Devic's Neuromyelitis Optica; Devic Syndrome; Devic's Disease; Devic Disease
NCT03002038

Completed

Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients

Conditions: Neuromyelitis Optica Spectrum Disorder
NCT02850705

Recruiting

The French Cohort and Biobank of Devic's Neuromyelitis Optica and Related Neurological Disorders (NMOSD) (NOMADMUS)

Conditions: Neuromyelitis Optica Spectrum Disorders; Neuromyelitis Optica Spectrum Related Disorders
NCT02021825

Unknown status

Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders

Conditions: Neuromyelitis Optica; Neuromyelitis Optica Spectrum Disorders
NCT01500681

Active, not recruiting

Maintenance Plasma Exchange for Neuromyelitis Optica

Conditions: Neuromyelitis Optica; Neuromyelitis Optica Spectrum Disorder; Recurrent Idiopathic Longitudinally Extensive Transverse Myelitis
NCT01777412

Completed

Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations

Conditions: Neuromyelitis Optica; Neuromyelitis Optica Spectrum Disorder